Palavra-chave: NILOTINIB

PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKAEMIA IMATINIB CHRONIC MYELOID LEUKEMIA BCR-ABL CHRONIC MEYLOID LEUKEMIA ENESTCMR SECOND-GENERATION BCR-ABL1 TYROSINE KINASE INHIBITORS DASATINIB THIRD-LINE TKI TREATMENT CML CHRONIC MYELOID LEUCEMIA (CML) ENACT STUDY CHRONIC MYELOID LEUKEMIA (CML) SUBOPTIMAL RESPONCE IMATINIB ENACT CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE IMATINIB-RESISTANT LEUCEMIA MIELÓIDE CRÔNICA (LMC-PB) CYR SUBOPTIMAL RESPONSES LASOR CHRONIC PHASE LEUCEMIA MIELOIDE CRÔNICA